US Patent Issued to KisoJi Biotechnology on April 15 for "Binding agents targeting TROP2-expressing tumor cells" (Canadian Inventors)

ALEXANDRIA, Va., June 5 -- United States Patent no. 12,275,799, issued on April 15, was assigned to KisoJi Biotechnology Inc. (Montreal).

"Binding agents targeting TROP2-expressing tumor cells" was invented by Wenyang Hou (Montreal, Canada), Shugang Yao (Montreal, Canada), Luis Da Cruz (Montreal, Canada) and David S. Young (Montreal, Canada).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure generally relates to binding agents, such as antibodies and antigen binding fragments thereof, that are capable of binding to trophoblast cell surface antigen-2 (TROP2). Also disclosed herein are binding agents that are capable of targeting TROP2-expressing tumor cells and their use for the treatment of...